Cancer Letters

Cancer Letters

Volume 231, Issue 1, 8 January 2006, Pages 129-137
Cancer Letters

Expression of sFRP-4 and β-catenin in human colorectal carcinoma

https://doi.org/10.1016/j.canlet.2005.01.026Get rights and content

Abstract

Alterations to the Wnt signalling pathway occur in the majority of colorectal cancers and result in abnormal accumulation of β-catenin. The secreted frizzled related proteins (sFRPs) are antagonists that bind Wnt and inhibit signalling along this pathway. We investigated expression of the sFRP family member, sFRP-4, and β-catenin in 1044 human colorectal carcinomas using tissue microarrays and immunohistochemistry. Both proteins showed markedly increased expression levels in tumors compared to normal mucosa, but no significant associations with pathological features or with patient outcome. sFRP-4 was co-expressed with β-catenin, p53, and COX-2, while the absence of β-catenin expression was strongly associated with loss of expression of the MLH1 mismatch repair gene. In contrast to other sFRP family members, sFRP-4 expression appears to be upregulated in colorectal carcinoma.

Introduction

Wnt genes encode a large family of secreted proteins that play key roles as intercellular signalling molecules in development. The transduction of Wnt signals between cells proceeds via a complex series of events that include post-translational modification and secretion of Wnts, binding to transmembrane receptors, activation of cytoplasmic effectors and transcriptional regulation of target genes [1]. In adult tissues, Wnt signalling is involved in proliferation, differentiation and apoptotic pathways [2]. Aberrant regulation of the Wnt signalling pathway has therefore been suggested to play a role in tumorigenesis [3] and in particular the development of colorectal cancer [4]. This occurs mainly through mutations in APC but also of the CTNNB1 gene encoding β-catenin [5], [6]. Mutation of these genes leads to ligand-independent Wnt signalling and results in the abnormal accumulation of free β-catenin in the nucleus. This in turn activates transcription factors such as T-cell factor to induce the expression of target genes involved in cell proliferation, including c-myc and cyclin D1.

Secreted Frizzled Related Proteins (sFRPs) are antagonists that bind directly to Wnts and prevent them from binding to their receptors [7]. They contain a cysteine-rich domain with similarity to the ligand-binding domain of the Frizzled transmembrane protein family, but lack the transmembrane component required for anchoring to the plasma membrane [8]. The inhibitory effects of sFRPs on Wnt signalling have been demonstrated in Xenopus embryos as well as in cultured cells [9], [10], while the expression pattern of several sFRPs complement those of specific Wnts, possibly indicating direct antagonism of Wnt function.

Hypermethylation of the promoter region of sFRP genes occurs frequently in colorectal tumors and is associated with the transcriptional silencing of these genes [11], [12]. Tumor cells may gain a selective advantage by shutting down the expression of normally proapoptotic sFRPs [13], [14]. Epigenetic loss of sFRP function occurs early in colorectal cancer progression and may thus lead to constitutive Wnt signalling that complements downstream mutations [12]. Restoration of sFRP function in colorectal cancer cells has been shown to attenuate Wnt signalling even in the presence of downstream mutations [12].

In the present study we investigated the expression of one of the sFRP family members, sFRP-4, together with β-catenin in a large cohort of colorectal tumors by using tissue microarrays (TMA) and immunohistochemistry (IHC). This has allowed us to examine the pattern of expression of these proteins in relation to each other and to various pathological and molecular features including prognosis.

Section snippets

Study population

A total of 1044 archived specimens from surgically treated colorectal cancer diagnosed at the PathCentre, Sir Charles Gairdner Hospital, Western Australia between 1990 and 1999 were included in the study. Diagnosis as Dukes’ stage B or C on the pathology report was the only selection criteria used for inclusion in the study. Patient demographics and additional tumor features (anatomical site, histological grade, and mucin content) were also obtained from pathology records. The splenic flexure

sFRP-4 expression in normal colorectal mucosa and colorectal carcinoma

sFRP-4 immunostaining was observed at low levels in the cytoplasm of normal colonic mucosal cells (Fig. 1A) and more often in the cytoplasm of tumor cells (Fig. 1B). No staining was observed in the absence of primary antibody. Using >20% immunopositive cells as the cut-off score, 12% of normal colorectal mucosal samples were deemed positive for expression of sFRP-4. Significantly higher levels of sFRP-4 expression were observed in the normal colonic mucosa from the proximal (16%, 68/416)

Discussion

sFRP-4, one of the five sFRP family members, was first cloned in 1997 and identified as a gene associated with the apoptotic involution of reproductive organs such as the mammary gland and corpus luteum [13], [17]. Like its sFRP relatives, sFRP-4 is a secreted protein with an N-terminal cysteine rich domain that binds to both the frizzled receptor and Wnt ligands to antagonise the Wnt signalling pathway [18]. The relationship between sFRP expression and downstream changes in β-catenin

Acknowledgements

We are grateful to Stan Krajewski, Maryla Krajewska and Lisa Spalding for assistance with construction of the tissue microarrays. This work was supported by the Cancer Council of Western Australia and the National Nature Science Foundation of China (30271283).

References (35)

  • A. Rattner et al.

    A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors

    Proc. Natl Acad. Sci. USA

    (1997)
  • K. Lin et al.

    The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling

    Proc. Natl Acad. Sci. USA

    (1997)
  • A.N. Salic et al.

    Sizzled: a secreted Xwnt8 antagonist expressed in the ventral marginal zone of Xenopus embryos

    Development

    (1997)
  • H. Suzuki et al.

    A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

    Nat. Genet.

    (2002)
  • H. Suzuki et al.

    Epigenetic inactivation of sFRP genes allows constitutive WNT signaling in colorectal cancer

    Nat. Genet.

    (2004)
  • M.D. Lacher et al.

    Role of DDC-4/sFRP-4, a secreted frizzled-related protein, at the onset of apoptosis in mammary involution

    Cell. Death Differ.

    (2003)
  • K. Guo et al.

    Apoptosis-associated gene expression in the corpus luteum of the rat

    Biol. Reprod.

    (1998)
  • Cited by (49)

    • The logistics of Wnt production and delivery

      2023, Current Topics in Developmental Biology
    • SFRPs Are Biphasic Modulators of Wnt-Signaling-Elicited Cancer Stem Cell Properties beyond Extracellular Control

      2019, Cell Reports
      Citation Excerpt :

      As observed in colorectal carcinoma, SFRP4 was found to co-express with β-catenin, p53, and COX-2, whereas the absence of β-catenin expression was strongly associated with the loss of expression of the MLH1 mismatch repair gene. These data indicate that SFRP4 may function as an oncogene that serves as a cross-point of the Wnt and other signaling pathways (Feng Han et al., 2006). We showed that SFRP3 and SFRP4 not only enhanced the recruitment of β-catenin to TCF4 but also promoted β-catenin/TCF-mediated transcriptional activity and the CSC phenotype.

    • Wnt inhibition is dysregulated in gliomas and its re-establishment inhibits proliferation and tumor sphere formation

      2016, Experimental Cell Research
      Citation Excerpt :

      Upregulation of SFRP4 was also associated with an unfavorable clinical prognosis, indicating that SFRP4 may initiate Wnt signaling in GSCs. Such a Wnt-agonistic SFRP4 effect has previously been observed in colorectal cancer cells [41,42]. In fact, SFRP1 and SFRP4 belong to different SFRP subgroups based on sequence homology and antagonize one another's activity [14,43].

    • An informatics-assisted label-free approach for personalized tissue membrane proteomics: Case study on colorectal cancer

      2011, Molecular and Cellular Proteomics
      Citation Excerpt :

      Negative control reactions were conducted by omitting the primary antibody. Immunostaining was evaluated and scored by two experienced pathologists who were blinded to any knowledge of clinical or pathological parameters and clinical outcome as described previously (37, 38). The percentage of STOML2-positive tumor cells was determined semiquantitatively by assessing the entire tumor section.

    View all citing articles on Scopus
    View full text